Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 16 studies | 58% ± 23% | |
| oligodendrocyte | 14 studies | 45% ± 17% | |
| glutamatergic neuron | 12 studies | 58% ± 26% | |
| GABAergic neuron | 10 studies | 53% ± 22% | |
| astrocyte | 8 studies | 30% ± 13% | |
| cardiac muscle cell | 6 studies | 59% ± 16% | |
| neuron | 5 studies | 42% ± 13% | |
| interneuron | 5 studies | 48% ± 26% | |
| endothelial cell | 4 studies | 35% ± 19% | |
| granule cell | 4 studies | 41% ± 13% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 55% ± 12% | |
| GABAergic amacrine cell | 3 studies | 29% ± 9% | |
| glycinergic amacrine cell | 3 studies | 20% ± 4% | |
| smooth muscle cell | 3 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 750.91 | 2606 / 2642 | 96% | 20.03 | 680 / 705 |
| ovary | 58% | 115.54 | 105 / 180 | 1% | 0.03 | 4 / 430 |
| adrenal gland | 25% | 52.50 | 64 / 258 | 22% | 1.30 | 51 / 230 |
| pancreas | 22% | 24.93 | 71 / 328 | 19% | 1.28 | 34 / 178 |
| prostate | 7% | 15.07 | 18 / 245 | 1% | 0.10 | 7 / 502 |
| bladder | 5% | 5.81 | 1 / 21 | 2% | 0.15 | 12 / 504 |
| adipose | 7% | 8.35 | 80 / 1204 | 0% | 0 | 0 / 0 |
| uterus | 2% | 4.14 | 4 / 170 | 3% | 0.18 | 12 / 459 |
| skin | 1% | 0.74 | 12 / 1809 | 1% | 0.08 | 5 / 472 |
| intestine | 1% | 0.48 | 5 / 966 | 1% | 0.11 | 6 / 527 |
| lung | 1% | 0.53 | 3 / 578 | 1% | 0.04 | 8 / 1155 |
| breast | 0% | 0.34 | 2 / 459 | 1% | 0.08 | 8 / 1118 |
| esophagus | 0% | 0.34 | 6 / 1445 | 0% | 0 | 0 / 183 |
| blood vessel | 0% | 0.30 | 5 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 0% | 0.19 | 1 / 359 | 0% | 0 | 0 / 286 |
| kidney | 0% | 0 | 0 / 89 | 0% | 0.02 | 2 / 901 |
| heart | 0% | 0.15 | 1 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| thymus | 0% | 0 | 0 / 653 | 0% | 0 | 0 / 605 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1902004 | Biological process | positive regulation of amyloid-beta formation |
| GO_1905606 | Biological process | regulation of presynapse assembly |
| GO_0051965 | Biological process | positive regulation of synapse assembly |
| GO_0098978 | Cellular component | glutamatergic synapse |
| GO_0005615 | Cellular component | extracellular space |
| GO_0098839 | Cellular component | postsynaptic density membrane |
| GO_0031012 | Cellular component | extracellular matrix |
| Gene name | LRRTM3 |
| Protein name | Leucine-rich repeat transmembrane neuronal protein 3 |
| Synonyms | UNQ803/PRO1693 |
| Description | FUNCTION: Exhibits a limited synaptogenic activity in vitro, restricted to excitatory presynaptic differentiation (By similarity). May play a role in the development and maintenance of the vertebrate nervous system. . |
| Accessions | ENST00000361320.5 [Q86VH5-1] Q86VH5 |